PEN Q2 2022 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$208M+13.1% YoY

Gross Profit

$134M64.3% margin

Operating Income

-$139,000-0.1% margin

Net Income

-$4M-1.8% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$44M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$358M

Stockholders' Equity

$970M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$208M	$184M	+13.1%
Gross Profit	$134M	$119M	+12.9%
Operating Income	-$139,000	$10M	-101.3%
Net Income	-$4M	$9M	-139.9%

Revenue Segments

Peripheral Vascular

$124M59%

Neuro

$85M41%

Geographic Segments

UNITED STATES

$141M68%

Other Non-US

$67M32%